94 related articles for article (PubMed ID: 9316853)
1. Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO.
Leventhal L; Stevens LB; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 1997 Sep; 282(3):1402-7. PubMed ID: 9316853
[TBL] [Abstract][Full Text] [Related]
2. Morphine-6beta-glucuronide-induced hyperphagia: characterization of opioid action by selective antagonists and antisense mapping in rats.
Leventhal L; Silva RM; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 1998 Nov; 287(2):538-44. PubMed ID: 9808678
[TBL] [Abstract][Full Text] [Related]
3. Beta-endorphin-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
Silva RM; Hadjimarkou MM; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 2001 May; 297(2):590-6. PubMed ID: 11303047
[TBL] [Abstract][Full Text] [Related]
4. Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse.
Wu HE; Mizoguchi H; Terashvili M; Leitermann RJ; Hung KC; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2002 Nov; 303(2):867-73. PubMed ID: 12388674
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligodeoxynucleotides against the MOR-1 clone alter weight and ingestive responses in rats.
Leventhal L; Cole JL; Rossi GC; Pan YX; Pasternak GW; Bodnar RJ
Brain Res; 1996 May; 719(1-2):78-84. PubMed ID: 8782866
[TBL] [Abstract][Full Text] [Related]
6. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens.
Zhang M; Gosnell BA; Kelley AE
J Pharmacol Exp Ther; 1998 May; 285(2):908-14. PubMed ID: 9580643
[TBL] [Abstract][Full Text] [Related]
7. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
8. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections.
Martin TJ; Sim LJ; Selley DE; deMontis MG; Childers SR
Synapse; 1997 Nov; 27(3):177-82. PubMed ID: 9329153
[TBL] [Abstract][Full Text] [Related]
9. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
[TBL] [Abstract][Full Text] [Related]
11. Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats.
Stein JA; Znamensky V; Baumer F; Rossi GC; Pasternak GW; Bodnar RJ
Brain Res; 2000 May; 864(2):240-51. PubMed ID: 10802031
[TBL] [Abstract][Full Text] [Related]
12. DAMGO stimulates the hypothalamo-pituitary-adrenal axis through a mu-2 opioid receptor.
Eisenberg RM
J Pharmacol Exp Ther; 1993 Aug; 266(2):985-91. PubMed ID: 8394926
[TBL] [Abstract][Full Text] [Related]
13. Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration.
Azaryan AV; Clock BJ; Rosenberger JG; Cox BM
Can J Physiol Pharmacol; 1998 Mar; 76(3):278-83. PubMed ID: 9673791
[TBL] [Abstract][Full Text] [Related]
14. Functional mu opioid receptors are expressed in cholinergic interneurons of the rat dorsal striatum: territorial specificity and diurnal variation.
Jabourian M; Venance L; Bourgoin S; Ozon S; Pérez S; Godeheu G; Glowinski J; Kemel ML
Eur J Neurosci; 2005 Jun; 21(12):3301-9. PubMed ID: 16026468
[TBL] [Abstract][Full Text] [Related]
15. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin A(1-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
Silva RM; Grossman HC; Hadjimarkou MM; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 2002 May; 301(2):513-8. PubMed ID: 11961051
[TBL] [Abstract][Full Text] [Related]
18. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
[TBL] [Abstract][Full Text] [Related]
19. Intra-amygdalar injection of DAMGO: effects on c-Fos levels in brain sites associated with feeding behavior.
Levine AS; Olszewski PK; Mullett MA; Pomonis JD; Grace MK; Kotz CM; Billington CJ
Brain Res; 2004 Jul; 1015(1-2):9-14. PubMed ID: 15223361
[TBL] [Abstract][Full Text] [Related]
20. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
Tao R; Auerbach SB
J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
